Multi-dimensional dynamic health assessment method and system based on immune group diversity analysis

Through the multi-dimensional dynamic health assessment method of immune group diversity analysis, multi-dimensional TCR and BCR diversity data are integrated to generate comprehensive scores, solving the problems that are difficult to integrate and update in real time in the existing technology, and achieving the accuracy of individual immune health assessment and reliability.

CN119092135AInactive Publication Date: 2024-12-06SICHUAN CENT FOR TRANSLATIONAL MEDICINE OF TRADITIONAL CHINESE MEDICINE

Patent Information

Application Number
CN202411594373.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-11-09
Publication Date
2024-12-06
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Existing health assessment methods are difficult to effectively integrate and analyze multi-dimensional TCR and BCR diversity data, cannot update individual immune health status in real time, and lack a multi-dimensional comprehensive scoring mechanism, which affects the reliability and comparability of the assessment results.

Method used

Using a multi-dimensional dynamic health assessment method based on immune group diversity analysis, the diversity index calculation, standardized processing and TOPSIS score calculation are carried out on the evaluation samples by initializing the diversity data table of the immune group library to generate comprehensive scores to realize dynamic updates and real-time data. calculate.

Benefits of technology

Through multi-dimensional integration, reflect the overall health status of individuals, ensure the latest and accurate health assessment results, and improve the comparability and reliability of assessment results.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119092135A_ABST
    Figure CN119092135A_ABST
Patent Text Reader

Abstract

The invention relates to a multi-dimensional dynamic health assessment method and system based on immune group diversity analysis. The multi-dimensional dynamic health assessment method comprises the following steps: performing health assessment on a to-be-assessed immune group library sample based on an initialized immune group library diversity data table; the initialized immune repertoire diversity data table is obtained by performing diversity index calculation on a crowd immune repertoire sample data set; the multi-dimensional dynamic update health assessment method comprises the following steps: S1, performing diversity index calculation on an immune repertoire sample to be assessed to obtain diversity data to be assessed; s2, inserting diversity data to be evaluated into the initialized immune repertoire diversity data table; s3, normalizing the data of the initialized immune repertoire diversity data table to obtain standardized data; and S4, TOPSIS score calculation is carried out on the standardized data. The immune group libraries of multiple dimensions are diversified and integrated into a comprehensive score, the overall health condition of an individual is visually reflected, and data can be dynamically updated and calculated in real time.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of immune health assessment, and in particular to a multidimensional dynamic health assessment method and system based on immune group diversity analysis. Background Art

[0002] With the continuous advancement of biomedical technology, personalized health management has become a key trend in modern medicine. In this context, the study of the immune repertoire is particularly important. The immune repertoire includes T cell receptors (TCR) and B cell receptors (BCR), which are key antigen recognition molecules in the immune system. TCR is a receptor expressed on the surface of T cells, responsible for recognizing and binding antigen fragments, and activating T cells to initiate specific immune responses. BCR is an antibody receptor on the surface of B cells, which activates B cells to produce antibodies to neutralize or eliminate antigens by recognizing antigens directly or through antibody mediation. In the immune repertoire, diversity considers clonal composition, and in TCR / BCR sequencing data, it represents the number of unique sequences, called richness; the relative abundance of these sequences is called evenness. The ability to characterize the degree of diversity can provide valuable tools for understanding the normal state of immune response and pathology during autoimmune diseases, viral infections and cancer, and can provide useful diagnosis or guide immunotherapy. Therefore, the diversity of TCR and BCR directly affects the individual's recognition of various antigens and the breadth and specificity of immune response.

[0003] The diversity of the immune repertoire reflects the ability of an individual's immune system to respond to different antigens. A highly diverse immune repertoire means that an individual can recognize a wider range of antigens and show a more complex and effective immune response, thereby improving the ability to resist disease and pathogen invasion. On the contrary, low diversity of the immune repertoire may lead to insufficient recognition and response of the immune system to certain antigens, increasing the risk of certain diseases. Diversity indices can be divided into species richness index, species evenness index and species diversity index: the richness index reflects the richness of species in the community, and common ones include Sobs, Chao1 index, ACE, etc. The evenness index reflects the uniformity of the relative abundance of species in the community, and common ones include Pielou index and D50. Some diversity indices reflect the comprehensive status of richness and evenness, and common ones include Shannon index and Simpson index. The comprehensive analysis of these indicators can help to more comprehensively evaluate the immune health status of individuals, predict potential disease risks, and provide important basis for precision medicine and personalized treatment. By deeply understanding and analyzing the diversity of TCR and BCR, people can better understand the immune function status of individuals and provide more precise support for future health management and medical strategies.

[0004] Current health assessment methods face many challenges when dealing with immune repertoire diversity data. First, the diversity data of TCR and BCR involve multiple dimensions, and traditional health assessment methods are difficult to effectively integrate and analyze these complex data. Secondly, the immune status of an individual is dynamically changing, and existing assessment systems often cannot update and reflect the latest changes in individual immune health in real time. In addition, existing methods mostly rely on a single or a few indicators, lack a multi-dimensional comprehensive scoring mechanism, and are difficult to fully and accurately reflect the individual's immune health status. Finally, there are significant differences in TCR and BCR diversity among different individuals, and there is a lack of effective standardized processing methods, which affects the reliability and comparability of the assessment results. Summary of the invention

[0005] The purpose of the present invention is to overcome the shortcomings of the prior art and provide a multidimensional dynamic health assessment method and system based on immune group diversity analysis, which integrates the diversity of the immune group library in multiple dimensions into a comprehensive score, intuitively reflects the overall health status of the individual, and can dynamically update data for real-time calculation.

[0006] The objective of the present invention is achieved through the following technical solutions: A multidimensional dynamic health assessment method based on immune group diversity analysis, wherein the multidimensional dynamic health assessment method performs health assessment on immune group library samples to be evaluated based on an initialized immune group library diversity data table; The initialized immune repertoire diversity data table is obtained by calculating the diversity index of the population immune repertoire sample data set; The multi-dimensional dynamic update health assessment method comprises the following steps: S1: Calculate the diversity index of the immune repertoire samples to be evaluated to obtain the diversity data to be evaluated; S2: insert the diversity data to be evaluated into the initialization immune repertoire diversity data table; S3: normalizing the data in the initialized immune repertoire diversity data table to obtain standardized data; S4: TOPSIS score calculation for normalized data.

[0007] Furthermore, the method for constructing the initialized immune repertoire diversity data table comprises the following steps: (1) Collecting a sample dataset of the population immune repertoire; (2) Calculating the diversity index for each sample in the population immune library sample data set to obtain diversity index data; (3) Add the diversity index data calculated in step (2) to the initialized immune repertoire diversity data table.

[0008] Furthermore, the diversity indexes calculated by the diversity index include but are not limited to: Chao1 index, D 50 index, Shannon index and Pielou index.

[0009] Furthermore, the normalization process is CDF normalization process.

[0010] Further, the CDF normalization process includes the following sub-steps: S301: constructing data area boundaries for data of each diversity index in the initialized immune repertoire diversity data table; S302: dividing the data interval corresponding to the data area boundary of each diversity indicator into equal parts and calculating the cumulative distribution function; S303: Map the data of each diversity index in the initialized immune repertoire diversity data table to the cumulative distribution function obtained in step S302 to obtain standardized data.

[0011] Further, the step S301 includes the following sub-steps: 1) The data of the initialized immune repertoire diversity data table is formed into multiple diversity data arrays according to diversity indicators; 2) Calculate the minimum, maximum, and standard deviation of each diversity data array; 3) For each diversity data array, the minimum value is used as the lower limit of the data area boundary, and the sum of the maximum value and 0.5 standard deviation is used as the upper limit of the data area boundary.

[0012] Further, the step S4 includes the following sub-steps: A. Construct the ideal solution vector Zmax and the negative ideal solution vector Zmin for each diversity index in the standardized data; B. Calculate the TOPSIS score of the immune library sample to be evaluated based on the ideal solution vector Zmax and the negative ideal solution vector Zmin: NS.score = dist(NS.Norm, Zmin) / [dist(NS.Norm, Zmin)+dist(NS.Norm,Zmax)]; In the formula, NS.score is the TOPSIS score, NS.Norm is the data corresponding to the immune repertoire sample to be evaluated in the standardized data, Zmax is the ideal solution vector, Zmin is the negative ideal solution vector, and dist(a, b) defines the distance between the two diversity index vectors a and b.

[0013] Further, the step A comprises the following sub-steps: a. Construct a standardized decision matrix for standardized data; With chao1_data_normalized, d50_data_normalized, shannon_data_normalized, and pielou_data_normalized as columns, a standardized decision matrix is ​​constructed. The last row vector of the standardized decision matrix is: NS.Norm=[NS.Norm.Chao1, NS.Norm.D50, NS.Norm.Shannon, NS.Norm.Pielou]; b. Take the maximum and minimum values ​​of each column of the standardized decision matrix to construct the ideal solution vector Zmax and the negative ideal solution vector Zmin respectively.

[0014] A multidimensional dynamic health assessment system based on immune group diversity analysis applies a multidimensional dynamic health assessment method based on immune group diversity analysis. The multidimensional dynamic health assessment system includes a data acquisition device and a data processing device; the data acquisition device acquires immune group library samples to be evaluated, and the data processing device performs health assessment on the immune group library samples to be evaluated based on an initialized immune group library diversity data table.

[0015] The beneficial effects of the present invention are: By integrating the diversity of multiple dimensions of the immune repertoire into a comprehensive score, it can intuitively reflect the overall health status of an individual. It can dynamically update the data in the database, calculate and update the health assessment results in real time, and ensure the latest reflection of the health status. BRIEF DESCRIPTION OF THE DRAWINGS

[0016] Figure 1 It is a flow chart of the present invention. DETAILED DESCRIPTION

[0017] The following describes the embodiments of the present invention by specific examples, and those skilled in the art can easily understand other advantages and effects of the present invention from the contents disclosed in this specification. The present invention can also be implemented or applied through other different specific embodiments, and the details in this specification can also be modified or changed in various ways based on different viewpoints and applications without departing from the spirit of the present invention. It should be noted that the following embodiments and features in the embodiments can be combined with each other without conflict.

[0018] It should be noted that the illustrations provided in the following embodiments are only schematic illustrations of the basic concept of the present invention, and thus the drawings only show components related to the present invention rather than being drawn according to the number, shape and size of components in actual implementation. In actual implementation, the type, quantity and proportion of each component may be changed arbitrarily, and the component layout may also be more complicated.

[0019] Embodiment 1: like Figure 1 As shown, a multidimensional dynamic health assessment method based on immune group diversity analysis is provided, wherein the multidimensional dynamic health assessment method performs health assessment on immune group library samples to be evaluated based on an initialized immune group library diversity data table.

[0020] The initialized immune repertoire diversity data table is obtained by calculating the diversity index of the population immune repertoire sample data set.

[0021] The method for constructing the initialized immune repertoire diversity data table comprises the following steps: (1) Collecting a sample dataset of the population immune repertoire; (2) Calculating the diversity index for each sample in the population immune library sample data set to obtain diversity index data; (3) Add the diversity index data calculated in step (2) to the initialized immune repertoire diversity data table.

[0022] For an existing immune repertoire sample data set of a certain population (different populations can be divided into different data sets, here we take the sample data set of healthy people as an example), multiple diversity indicators are calculated to construct an initialized immune repertoire diversity data table.

[0023] The diversity indexes calculated include but are not limited to: Chao1 index, D 50 index, Shannon index and Pielou index.

[0024] This embodiment is not limited to the number of diversity indicators. Here, four diversity indicators are taken as an example, namely: Table 1 Calculation formula for diversity index

[0025] Assuming that the population immune repertoire sample dataset has M samples, and the above four diversity indicators are calculated for each sample, the diversity data table will at least contain the following information: Sample ID: An identifier that uniquely identifies each sample, usually a number or a string.

[0026] Chao1 Index: Chao1 Index value of each sample.

[0027] D 50 Index: D for each sample 50 Index value.

[0028] Shannon Index: The Shannon Index value of each sample.

[0029] Pielou Index: The Pielou uniformity index value for each sample.

[0030] An example of the structure of the initialized immune repertoire diversity data table is as follows: Table 2 Examples of ImmunomeDiversity Sample ID Chao1 Index D50 Index Shannon Index Pielou Index Sample_1 Value 1 Value 1 Value 1 Value 1 Sample_2 Value 2 Value 2 Value 2 Value 2 ... ... ... ... ... Sample_M Value M Value M Value M Value M

[0031] The multi-dimensional dynamic update health assessment method comprises the following steps: S1: Calculate the diversity index of the immune repertoire samples to be evaluated to obtain the diversity data to be evaluated; Assume that there is an immune repertoire sample NewSample to be evaluated, and the diversity data to be evaluated calculated according to the formula in Table 1 are NS.Chao1, NS.D50, NS.Shannon and NS.Pielou.

[0032] S2: insert the diversity data to be evaluated into the initialization immune repertoire diversity data table; The calculated diversity data to be evaluated (corresponding to the immune repertoire sample NewSample to be evaluated) is inserted into the initialized immune repertoire diversity data table ImmunomeDiversity.

[0033] The new data row inserted into the database table ImmunomeDiversity contains: Table 3 New data row content inserted into the database table ImmunomeDiversity Sample ID Chao1 Index D50 Index Shannon Index Pielou Index NewSampleID NS.Chao1 NS.D50 NS.Shannon NS.Pielou The initialized immune repertoire diversity data table is a database table, and the data in the database table can be dynamically updated.

[0034] S3: normalizing the data in the initialized immune repertoire diversity data table to obtain standardized data; In order to eliminate the dimensional effects between different diversity indicators and make them comparable on the same scale, the data of each diversity indicator needs to be standardized.

[0035] The normalization process is CDF normalization process.

[0036] The CDF normalization process includes the following sub-steps: S301: constructing data area boundaries for data of each diversity index in the initialized immune repertoire diversity data table; 1) The data of the initialized immune repertoire diversity data table is formed into multiple diversity data arrays according to diversity indicators; Load all data from the initialized immune library diversity data table ImmunomeDiversity and store the data of each indicator in independent arrays to form four diversity data arrays (chao1_data, d50_data, shannon_data, pielou_data).

[0037] That is, the diversity index data of all samples is loaded from the initialization immune library diversity data table ImmunomeDiversity. The loaded data is stored in four independent arrays in the memory to form four diversity data arrays, namely: chao1_data: stores the Chao1 index data of all samples, where the last data is NS.Chao1.

[0038] d50_data: stores the D50 index data of all samples, with the last data being NS.D50.

[0039] shannon_data: stores the Shannon index data of all samples, the last of which is NS.Shannon.

[0040] pielou_data: stores the Pielou index data of all samples, where the last data is NS.Pielou.

[0041] 2) Calculate the minimum, maximum, and standard deviation of each diversity data array; Calculate the standard deviation chao1_std, d50_std, shannon_std, and pielou_std of each diversity data array, chao1_data, d50_data, shannon_std, and pielou_std, respectively, for the subsequent construction of data interval boundaries.

[0042] Calculate the maximum value chao1_max, d50_max, shannon_max, pielou_max and the minimum value chao1_min, d50_min, shannon_min, pielou_min of each diversity data array chao1_data, d50_data, shannon_data, and pielou_data respectively; 3) For each diversity data array, the minimum value is used as the lower limit of the data area boundary, and the sum of the maximum value and 0.5 standard deviation is used as the upper limit of the data area boundary; The maximum value plus 0.5 standard deviation is used as an additional boundary to obtain the upper limit of the data range boundary, thus obtaining the data range cousin.

[0043] The data interval corresponding to the chao1_data data area boundary: [chao1_min, chao1_max + 0.5 *chao1_std] d50_data Data area boundary corresponding to the data interval: [d50_min, d50_max + 0.5 * d50_std] The data interval corresponding to the shannon_data data area boundary: [shannon_min, shannon_max + 0.5* shannon_std] The data area boundary of pielou_data corresponds to the data interval: [pielou_min, pielou_max + 0.5 *pielou_std] S302: dividing the data interval corresponding to the data area boundary of each diversity indicator into equal parts and calculating the cumulative distribution function; The data intervals corresponding to the data area boundaries of each diversity indicator are equally divided (for example, into 10,000 intervals, and the division accuracy is set according to requirements), the frequencies in each data interval obtained by equal division are calculated, and then the frequency cumulative distribution function (CDF) is calculated.

[0044] The CDF represents the cumulative proportion of the data points in each bin and all the previous bins.

[0045] First, determine the data interval range of each data array, specifically [min_value, max_value +0.5 * std]. You can choose to divide this range into multiple intervals, and the number of equal divisions can be set according to needs, such as setting it to 10,000 intervals.

[0046] For each equally divided data interval, calculate the number of data points contained in the interval, that is, the frequency. These frequencies reflect the distribution of data in different intervals.

[0047] The cumulative distribution function (CDF) represents the cumulative proportion of the data points in each interval to all previous intervals and is calculated as follows: The frequencies are cumulatively summed to obtain the cumulative frequencies of each data interval; the cumulative frequencies are divided by the total number of data points to obtain the cumulative proportions of each data interval.

[0048] In this way, the cumulative distribution function (CDF) of each data array in the equally divided data interval can be obtained. chao1_CDF, d50_CDF, shannon_CDF, and pielou_CDF can reflect the relative position and distribution of data points in the entire data range.

[0049] S303: Mapping the data of each diversity index in the initialized immune repertoire diversity data table to the cumulative distribution function obtained in step S302 to obtain standardized data; That is, each element in the diversity data array is mapped to the cumulative distribution function (CDF) to obtain standardized data.

[0050] For each element in the diversity data array, find the cumulative proportion corresponding to the interval in the corresponding CDF based on the interval to which its value belongs in the equally divided data interval of the corresponding data array, and return the cumulative proportion as the standardized data.

[0051] For chao1_data, d50_data, shannon_data, and pielou_data, the data after CDF normalization are: chao1_data_normalized, d50_data_normalized, shannon_data_normalized, and pielou_data_normalized. The value range of these data is within (0, 1] to reflect their standardized position relative to the original data range. The dimension effect of the original data has been eliminated and can be used for subsequent statistical analysis, data comparison, or modeling.

[0052] This process ensures the comparability of data at different scales, so that the values ​​between different data arrays can be reasonably compared and analyzed. The last data in the four arrays of chao1_data, d50_data, shannon_data, and pielou_data is the four normalized indexes of the immune repertoire sample NewSample to be evaluated, namely: NS.Norm.Chao1, NS.Norm.D50, NS.Norm.Shannon, NS.Norm.Pielou.

[0053] S4: TOPSIS score calculation for normalized data.

[0054] A. Construct the ideal solution vector Zmax and the negative ideal solution vector Zmin for each diversity index in the standardized data; a. Construct a standardized decision matrix for standardized data; With chao1_data_normalized, d50_data_normalized, shannon_data_normalized, and pielou_data_normalized as columns, a standardized decision matrix is ​​constructed. The last row vector of the standardized decision matrix is: NS.Norm=[NS.Norm.Chao1, NS.Norm.D50, NS.Norm.Shannon, NS.Norm.Pielou].

[0055] b. Take the maximum and minimum values ​​of each column of the standardized decision matrix to construct the ideal solution vector Zmax and the negative ideal solution vector Zmin respectively.

[0056] B. Calculate the TOPSIS score of the immune library sample to be evaluated based on the ideal solution vector Zmax and the negative ideal solution vector Zmin: NS.score = dist(NS.Norm, Zmin) / [dist(NS.Norm, Zmin)+dist(NS.Norm,Zmax)] Where, NS.score is the TOPSIS score, NS.Norm is the data corresponding to the immune repertoire sample to be evaluated in the standardized data, Zmax is the ideal solution vector, Zmin is the negative ideal solution vector, and dist(a, b) defines the distance between two diversity index vectors a and b; the Euclidean distance can be used simply.

[0057] NS.score*100 is the health score of the immune library sample NewSample in percentage.

[0058] A multidimensional dynamic health assessment system based on immune group diversity analysis applies a multidimensional dynamic health assessment method based on immune group diversity analysis. The multidimensional dynamic health assessment system includes a data acquisition device and a data processing device; the data acquisition device acquires immune group library samples to be evaluated, and the data processing device performs health assessment on the immune group library samples to be evaluated based on an initialized immune group library diversity data table.

[0059] By integrating the diversity of the immune repertoire in multiple dimensions into a comprehensive score, it can intuitively reflect the overall health status of an individual. It can dynamically update the data in the database, calculate and update the health assessment results in real time, ensure the latest reflection of the health status, and obtain a more accurate population probability distribution function as more data accumulates in the system.

[0060] The system uses cumulative distribution function (CDF) mapping to perform data standardization, eliminate the dimensional impact between different individuals, and improve the comparability and reliability of the evaluation results.

[0061] The above-mentioned embodiments only express the specific implementation of the present invention, and the description thereof is relatively specific and detailed, but it cannot be understood as limiting the scope of the present invention. It should be pointed out that, for ordinary technicians in this field, several variations and improvements can be made without departing from the concept of the present invention, which all belong to the protection scope of the present invention.

Claims

1. A multidimensional dynamic health assessment method based on immune group diversity analysis, characterized by: The multidimensional dynamic health assessment method performs health assessment on immune repertoire samples to be assessed based on the initialized immune repertoire diversity data table; The initialized immune repertoire diversity data table is obtained by calculating the diversity index of the population immune repertoire sample data set; The multi-dimensional dynamic update health assessment method comprises the following steps: S1: Calculate the diversity index of the immune repertoire samples to be evaluated to obtain the diversity data to be evaluated; S2: insert the diversity data to be evaluated into the initialization immune repertoire diversity data table; S3: normalizing the data in the initialized immune repertoire diversity data table to obtain standardized data; S4: TOPSIS score calculation for normalized data.

2. The multidimensional dynamic health assessment method based on immune group diversity analysis according to claim 1, characterized in that: The method for constructing the initialized immune repertoire diversity data table comprises the following steps: (1) Collecting a sample dataset of the population immune repertoire; (2) Calculating the diversity index for each sample in the population immune library sample data set to obtain diversity index data; (3) Add the diversity index data calculated in step (2) to the initialized immune repertoire diversity data table.

3. The multidimensional dynamic health assessment method based on immune group diversity analysis according to claim 1, characterized in that: The diversity indexes calculated include but are not limited to: Chao1 index, D 50 index, Shannon index and Pielou index.

4. The multidimensional dynamic health assessment method based on immune group diversity analysis according to claim 1, characterized in that: The normalization process is CDF normalization process.

5. The multidimensional dynamic health assessment method based on immune group diversity analysis according to claim 4 is characterized in that: The CDF normalization process includes the following sub-steps: S301: constructing data area boundaries for data of each diversity indicator in the initialized immune repertoire diversity data table; S302: dividing the data interval corresponding to the data area boundary of each diversity indicator into equal parts and calculating the cumulative distribution function; S303: Map the data of each diversity index in the initialized immune repertoire diversity data table to the cumulative distribution function obtained in step S302 to obtain standardized data.

6. The multidimensional dynamic health assessment method based on immune group diversity analysis according to claim 5 is characterized in that: The step S301 includes the following sub-steps: 1) The data of the initialized immune repertoire diversity data table is formed into multiple diversity data arrays according to diversity indicators; 2) Calculate the minimum, maximum, and standard deviation of each diversity data array; 3) For each diversity data array, the minimum value is used as the lower limit of the data area boundary, and the sum of the maximum value and 0.5 standard deviation is used as the upper limit of the data area boundary.

7. The multidimensional dynamic health assessment method based on immune group diversity analysis according to claim 1, characterized in that: The step S4 comprises the following sub-steps: A. Construct the ideal solution vector Zmax and the negative ideal solution vector Zmin for each diversity index in the standardized data; B. Calculate the TOPSIS score of the immune library sample to be evaluated based on the ideal solution vector Zmax and the negative ideal solution vector Zmin: NS.score = dist(NS.Norm, Zmin) / [dist(NS.Norm, Zmin)+dist(NS.Norm, Zmax)] In the formula, NS.score is the TOPSIS score, NS.Norm is the data corresponding to the immune repertoire sample to be evaluated in the standardized data, Zmax is the ideal solution vector, Zmin is the negative ideal solution vector, and dist(a, b) defines the distance between the two diversity index vectors a and b.

8. The multidimensional dynamic health assessment method based on immune group diversity analysis according to claim 7 is characterized in that: The step A comprises the following sub-steps: a. Construct a standardized decision matrix for standardized data; With chao1_data_normalized, d50_data_normalized, shannon_data_normalized, and pielou_data_normalized as columns, a standardized decision matrix is ​​constructed. The last row vector of the standardized decision matrix is: NS.Norm=[NS.Norm.Chao1, NS.Norm.D50, NS.Norm.Shannon, NS.Norm.Pielou]; b. Take the maximum and minimum values ​​of each column of the standardized decision matrix to construct the ideal solution vector Zmax and the negative ideal solution vector Zmin respectively.

9. A multidimensional dynamic health assessment system based on immune group diversity analysis, using the multidimensional dynamic health assessment method based on immune group diversity analysis described in any one of claims 1 to 8, characterized in that: The multi-dimensional dynamic health assessment system includes a data acquisition device and a data processing device; the data acquisition device acquires immune repertoire samples to be assessed, and the data processing device performs health assessment on the immune repertoire samples to be assessed based on an initialized immune repertoire diversity data table.

Citation Information

Patent Citations

  • TOPSIS model-based mining remains comprehensive evaluation method

    CN111428989A

  • Immune state evaluation method and application

    CN113707316A

  • Immune repertoire health assessment system and method

    CN114424291A

  • Health assessment model fused with multi-dimensional immunity detection

    CN114496258A

  • Method for measuring a change in an individual s immunorepertoire

    IN201727034858A

Cited By

  • TCR-pMHC combined prediction method, model and system based on deep learning

    CN121215045A